The exterior of NeoGenomics’ headquarters in Fort Myers. The company provides oncology diagnostic and precision medicine testing services.
Fort Myers-based NeoGenomics has named President and Chief Operating Officer Warren Stone its next CEO as part of a planned leadership transition. Stone, 54, will become CEO and join the cancer diagnostics company’s board Jan. 4. He joined NeoGenomics in 2022 and previously served as president of Clinical Services and chief commercial officer. Current CEO Tony Zook will become executive chairman. Board Chair Lynn Tetrault will step down as chair but remain an independent director until the company’s 2027 annual meeting. NeoGenomics also expects third-quarter revenue of approximately $209 million, with next-generation sequencing revenue growing about 28% year over year.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.